1. ADC Review. What are antibody-drug conjugates (ADCs)? 2019. https://www.adcreview.com/the-review/antibody-drug-conjugates/what-are-antibody-drug-conjugates/. Accessed 16 Jul 2021.
2. RemeGen. Disitamab vedotin: Chinese prescribing information. Yantai 2021.
3. Li L, Xu MZ, Wang L, et al. Conjugating MMAE to a novel anti-HER2 antibody for selective targeted delivery. Eur Rev Med Pharmacol Sci. 2020;24(24):12929–37.
4. RemeGen. Products: product pipeline. 2021. http://www.remegen.com/. Accessed 16 July 2021.
5. National Medical Products Administration. Disitamab vedotin: NMPA Approval notice. 2021. https://www.nmpa.gov.cn/yaowen/ypjgyw/20210609085452194.html. Accessed 9 Sep 2021.